Clinical Trial Update: AcrySof® IQ ReSTOR® +3.0 D Multifocal Toric Intraocular Lens (IOL) Clinical Study in Japan [NA]

View source ↗

Summary

Clinical trial update for the AcrySof IQ ReSTOR +3.0 D Multifocal Toric Intraocular Lens in Japan. The study has completed and results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataracts

Drugs mentioned

• AcrySof IQ ReSTOR +3.0 D Multifocal Toric Intraocular Lens (intraocular lens)

Snippet

Sponsor: Alcon Research | Conditions: Cataracts | NA | Status: COMPLETED | Results posted: 2017-03-06